Korva rescues the ideas worth keeping from podcasts. Each one becomes a Card.
In SURMOUNT-1, tirzepatide reduced prediabetes progression to type 2 diabetes by 94% over three years.
Don't lose this one.
Save this Card and explore the idea further in Korva.